Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. AstraZeneca Pharma India Limited
  6. Summary
    506820   INE203A01020

ASTRAZENECA PHARMA INDIA LIMITED

(506820)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Bombay Stock Exchange
01/21/2022 01/24/2022 01/25/2022 01/27/2022 01/28/2022 Date
2996.6 2838.5 2811.35 2823 2815.55 Last
956 5099 2149 1805 1293 Volume
-0.58% -5.28% -0.96% +0.41% -0.26% Change
Estimated financial data (e)
Sales 2020 8 318 M 111 M 111 M
Net income 2020 722 M 9,62 M 9,62 M
Net cash position 2020 2 407 M 32,1 M 32,1 M
P/E ratio 2020 82,8x
Yield 2020 0,04%
Sales 2021 8 136 M 108 M 108 M
Net income 2021 933 M 12,4 M 12,4 M
Net cash position 2021 3 402 M 45,3 M 45,3 M
P/E ratio 2021 80,7x
Yield 2021 0,07%
Capitalization 70 389 M 936 M 938 M
EV / Sales 2020 6,90x
EV / Sales 2021 8,83x
Nbr of Employees -
Free-Float 18,0%
More Financials
Company
AstraZeneca Pharma India Limited is a global biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of medicines for core areas of healthcare, including cardiovascular/metabolic disease, cancer and respiratory, inflammatory and autoimmune disease. The Company operates through two segments: Healthcare and Clinical Trial. The Healthcare segment engages in the manufacture... 
Sector
Pharmaceuticals
Calendar
02/07Earnings Release
More about the company
All news about ASTRAZENECA PHARMA INDIA LIMITED
2021AstraZeneca Pharma India Limited Appoints Shilpa Shridhar Divekar as Additional Directo..
CI
2021AstraZeneca Pharma India's Net Profit Slumps in Fiscal Q2
MT
2021ASTRAZENECA PHARMA INDIA : Gets Import Nod for Selumetinib
MT
2021ASTRAZENECA PHARMA INDIA LIMITED : Ex-dividend day for interim dividend
FA
2021AstraZeneca Pharma India Limited Approves the Payment of Interim Dividend for the Finan..
CI
2021AstraZeneca Pharma India Limited Approves the Declaration of Interim Dividend, Payable ..
CI
2021ASTRAZENECA PHARMA INDIA : Net Profit Slides in Fiscal Q1
MT
2021Indian Indices End Higher on Monday, Boosted by Banks and Information Technology Shares
MT
2021Astrazeneca Pharma India Limited Reports Earnings Results for the First Quarter Ended J..
CI
2021AstraZeneca Pharma India Limited Proposes Payment of Interim Dividend for the Financial..
CI
2021ProAxsis Signs Global In-Licensing Agreement with AstraZeneca for Covid-19 Serology Tes..
CI
2021AstraZeneca Pharma India Limited Announces Termination of Distribution Agreement with A..
CI
2021Sun Pharma Laboratories Limited Updates on Distribution Agreement with Astrazeneca Phar..
CI
2021ASTRAZENECA PHARMA INDIA : Net Profit Soars in Fiscal Q4
MT
2021Astrazeneca Pharma India Limited Reports Earnings Results for the Fourth Quarter Ended ..
CI
More news
News in other languages on ASTRAZENECA PHARMA INDIA LIMITED
2021AstraZeneca Pharma India Limited nomme Shilpa Shridhar Divekar au poste de directeur su..
2021AstraZeneca Pharma India Limited approuve le versement d'un dividende intérimaire pour ..
2021AstraZeneca Pharma India Limited approuve la déclaration d'un dividende intérimaire, pa..
2021Les indices indiens terminent en hausse lundi, soutenus par les banques et les actions ..
2021AstraZeneca Pharma India Limited propose le versement d'un dividende intérimaire pour l..
More news
Chart ASTRAZENECA PHARMA INDIA LIMITED
Duration : Period :
AstraZeneca Pharma India Limited Technical Analysis Chart | 506820 | INE203A01020 | MarketScreener
Technical analysis trends ASTRAZENECA PHARMA INDIA LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Gagandeep Singh Bedi Managing Director & Executive Director
Rajesh Marwaha Chief Financial Officer & Executive Director
Narayan Keelveedhi Seshadri Non-Executive Chairman
Pratap Rudra Secretary, Compliance Officer & Legal Counsel
Revathy Ashok Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PHARMA INDIA LIMITED-9.19%938
JOHNSON & JOHNSON-0.28%449 095
ROCHE HOLDING AG-6.46%307 637
PFIZER, INC.-9.62%299 559
ABBVIE INC.0.42%240 379
NOVO NORDISK A/S-12.29%219 960